eIF4A3-IN-1 (compound 53a) 是一种选择性的真核起始因子 4A3 (eIF4A3) 抑制剂 (IC50=0.26 μM; Kd=0.043 μM),eIF4A3-IN-1 与 eIF4A3 的非 ATP 结合位点结合,并在 10 μM 和 3 μM 时明显抑制细胞无义介导的 RNA 衰变 (NMD), 可作为进一步研究 eIF4A3、外显子连接复合体 (EJC) 和 NMD 的探针。
Cas No. | 2095486-67-0 |
Canonical SMILES | ClC(C=C1)=CC=C1[C@@H]2N(C(C3=CC=C(Br)C=C3)=O)CCN(C(C4=C(C)N(C5=CC=CC(C#N)=C5)N=C4)=O)C2 |
分子式 | C29H23BrClN5O2 |
分子量 | 588.88 |
溶解度 | Soluble in DMSO |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | eIF4A3-IN-1 (compound 53a) is a selective eukaryotic initiation factor 4A3 (eIF4A3) inhibitor (IC50=0.26 μM; Kd=0.043 μM), which binds to a non-ATP binding site of eIF4A3 and shows significant cellular nonsense-mediated RNA decay (NMD) inhibition at 10 and 3 μM and can be as a probe for further study of eIF4A3, the exon junction complex (EJC), and NMD[1].
IC50: 0.2 μM (eIF4A3)[1]Kd: 0.043 μM (eIF4A3)[1] [1]. Ito M, et al. Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors. J Med Chem. 2017 Apr 27;60(8):3335-3351. |